• HIV-1 Signaling Remodels Nuclear Pores to Enable T Cell Infe

  2026-07-20

  The referenced study uncovers how HIV-1 exploits cell–cell contact-induced signaling to remodel nuclear pores, overcoming intrinsic barriers in resting CD4+ T cells. This mechanism fundamentally advances our understanding of HIV-1 permissivity and may reshape future antiviral and cell signaling research.

• VEGFC–VEGFR-3 Axis Inhibition Reduces NASH-Driven Liver Fibr

  2026-07-19

  This study elucidates how downregulation of the VEGFC–VEGFR-3 axis, via genetic and pharmacologic approaches, protects against hepatic fibrosis in a NASH mouse model. The findings identify hepatocyte-derived VEGFC as a driver of macrophage infiltration and phenotypic imbalance, offering mechanistic insight for anti-lymphangiogenic strategies in metabolic liver disease.

• Aminocoumarin Fluorescent Probe Illuminates HO-1 Regulation

  2026-07-18

  This study introduces AMC-Hem, a novel aminocoumarin-based fluorescent probe designed to measure real-time heme oxygenase-1 (HO-1) activity in live human macrophages. The probe achieves enhanced sensitivity and spatial resolution, revealing previously unappreciated aspects of HO-1 regulation and localization relevant to vascular disease mechanisms.

• SAR131675: Precision VEGFR-3 Inhibition for Metabolic Diseas

  2026-07-17

  Explore how SAR131675, a potent VEGFR-3 inhibitor, enables advanced modeling of lymphangiogenesis, fibrosis, and tumor growth in metabolic disease research. This article offers unique, protocol-level guidance and critical analysis beyond existing reviews.

• DAPT (GSI-IX) in Organoid and Notch Pathway Research Workflo

  2026-07-17

  DAPT (GSI-IX) empowers precise control of Notch signaling, unlocking advanced disease modeling and high-fidelity organoid systems. This guide delivers protocol-ready workflows, troubleshooting strategies, and practice-based insights for translational research with γ-secretase inhibition.

• HyperScribe All in One mRNA Synthesis Kit: Advanced Workflow

  2026-07-16

  The HyperScribe All in One mRNA Synthesis Kit streamlines ARCA-capped, polyadenylated mRNA production for applications ranging from vaccine prototyping to RNAi research. Its robust yields, workflow efficiency, and proven translational relevance make it a preferred tool for next-generation mRNA innovation.

• SAR131675: Precision VEGFR-3 Inhibitor Workflows in Fibrosis

  2026-07-16

  SAR131675 redefines VEGFR-3 pathway interrogation, enabling researchers to dissect lymphangiogenesis, angiogenesis, and immune modulation with nanomolar precision in preclinical fibrosis and tumor models. This guide translates the latest evidence and troubleshooting insights into actionable workflow enhancements for robust, reproducible results.

• Pharmacokinetics and In Vivo Utility of RG108 as a DNMT Inhi

  2026-07-15

  This study provides the first detailed pharmacokinetic analysis of RG108, a non-nucleosidic DNA methyltransferase inhibitor, in rat models. The findings highlight RG108’s suitability for in vivo epigenetic modulation due to its favorable plasma and tissue concentrations, low cytotoxicity, and potential for broader disease applications beyond oncology.

• BAY-826: Potent Small Molecule Inhibitor for Retinal Assays

  2026-07-15

  BAY-826 delivers unmatched selectivity and potency for dissecting angiopoietin and PEDF signaling in retinal neuron survival models. Its robust workflow integration and clarity in troubleshooting set a new standard for neurovascular research involving Müller cell–neuron interactions.

• Zoledronic Acid in Cancer Cell Apoptosis: Protocols & Innova

  2026-07-14

  Zoledronic Acid stands out as a potent nitrogen-containing bisphosphonate for inducing apoptosis in cancer research, with robust, quantifiable effects across multiple models. This article delivers actionable workflows, troubleshooting tips, and key insights from recent studies—empowering translational scientists to optimize anti-cancer and bone disease assays.

• Propranolol: Advanced Mechanisms and Translational Precision

  2026-07-14

  Explore the multifaceted actions of Propranolol, a non-selective β-adrenergic receptor blocker, with a deeper look at its cardiovascular and neurobiological research uses. This article uniquely dissects molecular mechanisms, dosing logic, and translational assay design for scientists.

• 2-D08: Strategic Inhibition of Sumoylation for Translational

  2026-07-13

  This article explores the mechanistic and translational significance of 2-D08 (2’,3’,4’-trihydroxyflavone) for selective sumoylation inhibition in disease models. Drawing on recent advances in understanding SUMO-dependent mitophagy and referencing pivotal findings on the SENP2/HSPA8/FUNDC1 axis in bronchopulmonary dysplasia (BPD), we provide actionable guidance for translational researchers pursuing next-generation posttranslational modification strategies.

• Frizzled5 Cholesterol Sensing Links Lipid Metabolism to Wnt

  2026-07-13

  This study uncovers a unique mechanism by which the Frizzled5 receptor directly senses cholesterol, enabling aberrant lipid metabolism to drive Wnt/β-catenin signaling and tumor growth in pancreatic cancer. The findings provide mechanistic insight into metabolic-signaling crosstalk, revealing opportunities for targeted intervention in Wnt-dependent cancers.

• NSC-23766: Selective Rac GTPase Inhibitor for Cancer Researc

  2026-07-12

  NSC-23766 is a well-characterized Rac GTPase inhibitor that selectively blocks Rac1-GEF interaction, enabling precision targeting of Rac1 signaling pathways in cancer and stem cell research. Its ability to induce apoptosis in breast cancer cell lines while sparing normal cells makes it a critical tool for mechanistic studies.

• SAR131675: Decoding VEGFR-3 Inhibition in Tumor-Driven Lymph

  2026-07-10

  Discover how SAR131675, a selective VEGFR-3 inhibitor, advances our understanding of tumor-driven lymphangiogenesis and endothelial cell survival. This article unveils new insights into preclinical assay design, selectivity challenges, and translational hurdles in anti-angiogenic research.

453 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page